Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage ↓	Form	Price
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 90mg	90mg	Tablet, film coated	1,608,579 L.L
M01AH05	ARTRIX 90	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,228,656 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 8mg	8mg	Tablet	526,786 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	478,664 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
B01AC06	A.S HEART	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
B01AC06	ASPI-COR	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	690,735 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	353,239 L.L
B01AC06	ASPROTHIN	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	11,127,864 L.L
M04AA03	ADENURIC	B	Febuxostat - 80mg	80mg	Tablet, film-scored	2,127,111 L.L
C09CA03	ANGINET	G	Valsartan - 80mg	80mg	Tablet, film coated	387,027 L.L
C09CA03	ARBITEN 80	G	Valsartan - 80mg	80mg	Tablet	387,027 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
C09CA07	ARBIVASTEL	G	Telmisartan - 80mg	80mg	Tablet	667,890 L.L
M01AE03	ARDBEG 80MG ADULTS	G	Ketoprofen Lysine salt - 80mg	80mg	Powder for solution	634,294 L.L
A04AD12	APREPITANT BIOGARAN	G	Aprepitant - 80mg	80mg	Capsule	2,164,930 L.L
A07EC02	ASACOL	B	Mesalazine - 800mg	800mg	Tablet	6,833,439 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
M01AB05	ALMIRAL	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	415,247 L.L
B01AC04	AGGRIX 75	G	Clopidogrel besylate - 75mg	75mg	Tablet, film coated	1,204,083 L.L
B01AC04	ANTIPLEX	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	1,295,464 L.L
B01AC04	APO-CLOPIDOGREL	G	Clopidogrel (Bisulfate), - 75mg	75mg	Tablet	911,125 L.L
J01DC02	AXETINE	G	Cefuroxime sodium - 750mg	750mg	Injectable powder for solution	1,193,332 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
M05BA04	APO-ALENDRONATE	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet	981,005 L.L

...